- Projects & figures
- News & Events
- Managing your project
- About ERC
At the forefront of medicine, gene therapy is based on the insertion of genes into an individual's cells and tissues to treat a disease. Scientists are currently testing several approaches to this experimental technique. One of them, Prof. Seppo Ylä-Herttuala, intends to develop a novel method to treat myocardial ischemia by activating endogenous genes to propel angiogenesis. If successful, he will open a new era in gene therapy.
How does the past inform the lives of children and young people? A global team of EU-funded researchers is examining this issue by assessing how stories from classical antiquity impact on popular culture and society. The project’s results and outputs will provide valuable resources for scholars and teachers.
Malaria has always been the centre of attention for Dr Ali Salanti’s, a molecular parasitologist and an ERC grantee. With his studies, he hoped to bring new insight into pregnancy-associated malaria, to save the lives of women and their babies in areas affected by the disease. Now, Dr Salanti’s research has shifted to battling against another deadly disease: cancer. This comes after an unexpected discovery yielded ground-breaking results for the diagnosis and treatment of this illness. This is the kind of curiosity-driven research that can lead to ground-breaking serendipitous outcomes.
An international team of researchers, led by ERC grantee Prof Rune Linding, discovered how genetic cancer mutations attack the networks controlling human cells. This knowledge is critical for the future development of personalized precision cancer treatments.
The discovery, conquest, and subsequent colonization of the Americas gave rise to surprising, multifaceted encounters between the Old and New Worlds. These encounters were not limited to the first-contact phase or to the military subjugation of new lands by the Europeans. They have been long processes of cross-cultural communication—in which both sides participated equally—that continued to develop through the colonial and postcolonial eras up to the present day.
Prevention and early detection largely determine the outcome of most cancers. Prof. Päivi Peltomäki studies how tumours arise and progress, with a view to identifying biomarkers of our susceptibility to developing cancer. With the ERC grant, the team has created a single-step, early diagnosis kit for colorectal cancer.